DBD
DIEBOLD NIXDORF, Inc
Key Financials
Net Income
$94.6M
↑ 673.3%
Gross Profit
$961.2M
↑ 4.5%
Operating Income
$242.0M
↑ 32.9%
Total Liabilities
$2.7B
↑ 5.5%
Revenue
$3.8B
↑ 1.5%
Total Assets
$3.9B
↑ 8.8%
Shareholders' Equity
$1.1B
↑ 18.3%
Cash & Equivalents
$368.9M
↑ 24.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 7/31/2026 | View on SEC |
| 4 | 7/31/2026 | View on SEC |
| 10-Q | 7/29/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| SCHEDULE 13D/A | 6/26/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DBD |
| Company Name | DIEBOLD NIXDORF, Inc |
| CIK | 28823 |
| Sector | Calculating & Accounting Machines (No Electronic Computers) |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3578 |
| SIC Description | Calculating & Accounting Machines (No Electronic Computers) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 3304904000 |